40yo Woman with Painless Jaundice - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

40yo Woman with Painless Jaundice

Description:

40yo with multiple myeloma. 2wks ago, husband noted change in color of skin ... seen in association with multiple myeloma and Waldenstrom's macroglobulinemia ... – PowerPoint PPT presentation

Number of Views:539
Avg rating:3.0/5.0
Slides: 35
Provided by: kimjo8
Category:

less

Transcript and Presenter's Notes

Title: 40yo Woman with Painless Jaundice


1
40yo Woman with Painless Jaundice
  • Francis W. Chan, MD
  • GI Case Conference
  • Feb. 15, 2008

2
Admission History
  • HPI
  • 40yo with multiple myeloma
  • 2wks ago, husband noted change in color of skin
  • Increased fatigue, malaise
  • Mild nausea with several episodes of vomiting
  • No abdominal pain
  • Chronic diarrhea for past 2 months (on extended
    course of oral vanco for recurrent Cdiff)
  • No BRBPR/melena
  • No new meds. Not on chemo.
  • 15 lb wt loss over past 4 months
  • No fever/chills/night sweats

3
Admission History
  • PMHx
  • Multiple myeloma
  • Dx 2006
  • s/p thalidomide/decadron d/c due to severe rash
  • To be started on Revlamid/decadron
  • Disseminated varicella 4/07
  • Syncope, seizures, abdominal pain, encephalitis,
    diffuse skin involvement
  • Treated with acycolvir with complete resolution
  • Recurrent Cdiff since 8/07
  • Failed flagyl. On prolonged PO vanco taper.
  • SIADH

4
Admission History
  • Meds
  • Vanco 125 q6
  • Fentanyl patch 50mcg
  • ASA 325
  • Decadron 4mg qwk
  • Megace
  • Nexium
  • SocHx
  • No tobacco
  • No ETOH use
  • FamHx
  • No GI malignancy
  • No liver disease

5
Admission History
  • Exam
  • Vitals T 98.3 HR 95 BP 102/68
    RR 12
  • PERL, icteric, jaundiced, op clear, mmm, no LAD
  • RRR, no murmurs
  • CTAB
  • Abd soft, NDNT, 2cm below CM, no splenomegaly,
    decreased BS, no stigmata of chronic liver dz
  • Ext WWP, trace b/l LE edema
  • No rashes

6
Labs
  • WBC 5.7
  • Hct 31.9
  • Plt 205
  • MCV 92
  • 132 102 12
  • ---------------------------lt 111
  • 3.8 22 1.0
  • AG 8
  • Ca 9.4
  • Mg 1.8
  • Phos 2.6
  • TB/DB 9.3/6.6
  • AST/ALT 65/34
  • AlkP 583
  • Alb 2.3
  • INR 2.2

7
DDx?
8
Imaging
  • RUQ U/S
  • Hepatomegaly. No hepatic masses. No ascites.
  • No ductal dilatation.
  • Cholelithiasis. CBD 4mm. Questionable small
    echogenic filling defect in distal duct.
  • Patent vessels.
  • MRCP
  • Small amount of ascites. No liver lesions.
  • Mild prominence of intrahepatic ducts
  • CBD 4mm. No abnormal signal in CBD. PD
    non-dilated
  • Stones/sludge in GB with small amount of
    pericholecystic fluid.
  • Pancreatic atrophy with no definite mass
  • Abnormal BM signal in thoracolumbar spine with
    compression fractures and expansile 5th left rib
    lesion.

9
Labs
  • HAV IgM neg
  • HCV Ab neg
  • HBsAg neg
  • HBsAb neg
  • HBcAb IgM neg
  • HBeAg neg
  • ANA neg
  • ASMA neg
  • AMA neg
  • EBV IgM VCA neg
  • EBV IgG VCA pos
  • CMV IgM neg
  • CMV IgG pos
  • VZV IgM neg
  • VZB IgG neg
  • HSV IgM neg
  • HSV IgG neg

10
Labs
11
  • Next step in management?

12
Transjugular Liver Biopsy
13
Liver Bx.
14
Liver Bx.
15
Liver Bx.
16
Liver Bx.
17
Amyloidosis
  • Amyloid
  • Fibrils oriented in antiparallel ß-pleated sheet
  • Ability to bind Congo red
  • Primary Amyloid (AL)
  • Fibrils are composed of fragments of monoclonal
    light chains
  • Typically seen in association with multiple
    myeloma and Waldenstroms macroglobulinemia
  • Secondary Amyloid (AA)
  • fibrils composed of acute phase reactant serum
    amyloid A
  • Most commonly seen in association with rheumatic
    diseases

18
Hepatic and Gastrointestinal Amyloidosis
  • Can occur with AA and AL
  • Hepatic
  • 70 of pts with amyloidosis have hepatic
    involvement1
  • Typically presents with elevation in AlkP, AST,
    ALT with relatively normal bilis
  • Less commonly presents with severe cholestatic
    pattern with elevated bilis
  • Rarely progresses to hepatic failure
  • Gastrointestinal
  • Symptomatic in 30-60 of patients with primary
    amyloidosis2,3
  • Typically presents with
  • GIB
  • Malabsorption
  • Intestinal dysmotility
  • Protein losing enteropathy

1. Buck FS et el. Hum Pathol 1991 2. Gilat T,
Spiro H. Am J Dig Dis 1968 3. Lee JG, et
al.South Med J 1994
19
Gertz MA, Kyle RA. Am J Med 1988
20
Gertz MA, Kyle RA. Am J Med 1988
21
Park MA, et al. Medicine 2004
22
Park MA, et al. Medicine 2004
23
Median survival 8 months from diagnosis
Park MA, et al. Medicine 2004
24
Peters RA, et al. Gut 1994
25
Median survival 3 months from onset of jaundice
Peters RA, et al. Gut 1994
26
Follow up
  • On hospital day 10, developed BRBPR with no
    hemodynamic compromise
  • EGD and colonoscopy performed
  • EGD w/ multiple gastric erosions. No blood seen.
    Bx taken.
  • Colonoscopy w/ friable submucosal mass with
    ulceration at splenic flexure occupying ½ of
    lumen, approx 5cm in length. Copious amount of
    old blood throughout colon.

27
Follow up
  • On hospital day 11, recurrent BRBPR with
    hemodynamic compromise
  • EGD performed
  • Blood refluxing up esophagus
  • No lesions at GEJ
  • ½ of gastric mucosa covered with clot. Active
    oozing from underneath dependent clot. Gastric
    erosion with active oozing. Injected with 4cc
    Epi in 4 quadrants. Active oozing from needle
    puncture from injection. Cauterized with good
    hemostasis. Also with significant mucosal
    oozing.

28
Follow up
  • Progressive worsening of LFTs.
  • Peak TBil 27 and AlkP 1660
  • Gastric biopsies from EGD and colonoscopy.

29
Stomach Bx.
30
Stomach Bx.
31
Stomach Bx.
32
Colon Bx.
33
Colon Bx.
34
Follow up
  • Revlamid started with initial improvement, then
    worsening of LFTs
  • At approx hospital day 35 patient made comfort
    care and expired 2days later.
Write a Comment
User Comments (0)
About PowerShow.com